POP BIOTECHNOLOGIES INC — Federal Contracts, Awards & Government Contractor Profile

About POP BIOTECHNOLOGIES INC

POP Biotechnologies develops platform technologies using patented porphyrin-phospholipid (PoP) liposome technologies to create nanomedicines for infectious disease, oncology, and chronic diseases. The company has received funding from CEPI and NIH for vaccine and immunotherapy development.

Development of nanomedicines using PoP liposome technologiesAccelerated vaccine development via the SNAP platformTargeted chemotherapy using Chemophototherapy (CPT)Immunotherapy development for Alzheimer's diseaseLight-triggered release of materials from nanovesicles

Recent Federal Awards

Award	Agency	Amount	Date
POP TECHNOLOGIES, INC., "MULTIVALENT QS-18 PROTEIN NANOPARTICLES FOR A BROADLY PROTECTIVE INFLUENZA VIRUS VACC	Department of Health and Human Services	$600K
Federal contract award	Department of Health and Human Services	$600K

Is this your company?

Claim POP BIOTECHNOLOGIES INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim POP BIOTECHNOLOGIES INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.